Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Granulomatosis with polyangiitis (GPA)
- Radiologic Findings
- Fig 1. Chest radiograph demonstrates subpleural nodules in right apex and increased opacities in both lower lung fields.
Fig 2-5. Chest CT scan reveals diffuse bronchial wall thickening bilaterally, multiple small nodules with peripheral distribution, and clustered centrilobular opacities in the right lung.



- Brief Review
- Follow-up chest CT obtained one month later demonstrates progression with diffuse soft tissue thickening along the bronchovascular bundle and airway narrowing. Enlargement of multiple nodules is also noted.
The patient presented with fever and symptoms of paranasal sinusitis. Paranasal sinus (PNS) CT (not shown) revealed bilateral nasal polyps and maxillary and ethmoid sinusitis. Video-assisted thoracoscopic surgery (VATS) lung biopsy was performed to exclude infection and malignancy, revealing granulomatous inflammation with multinucleated giant cells and necrotizing vasculitis. Notably, the patient’s serum cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA) testing was negative, while perinuclear ANCA (p-ANCA) was positive.
Granulomatosis with polyangiitis (GPA) is a small‑vessel ANCA‑associated vasculitis characterized by necrotizing granulomatous inflammation of the respiratory tract and necrotizing vasculitis, often with pauci‑immune glomerulonephritis. The 2022 ACR/EULAR classification criteria require established small‑/medium‑vessel vasculitis (after excluding mimics), using a weighted scoring system where positive c‑ANCA/PR3‑ANCA and pulmonary nodules/masses/cavitation on chest imaging are major positive items, while p‑ANCA/MPO‑ANCA and marked eosinophilia are negative discriminators. Crucially, GPA can be classified even without c‑ANCA positivity if sufficient points are accrued from clinical, imaging, histologic, and laboratory findings. Thoracic imaging features include bilateral pulmonary nodules or masses (often subpleural or peribronchovascular, frequently cavitary), patchy consolidations or ground‑glass opacities, and less commonly interstitial lung disease; CT is the modality of choice, with pulmonary nodules/masses/cavities and sinonasal inflammation serving as key radiologic discriminators.
Airway involvement occurs in 15–55% of GPA patients and includes both large and small airway disease. The most characteristic lesion is circumferential subglottic stenosis, which begins as friable, edematous mucosa with ulceration and can progress to fixed fibrotic stenosis causing life‑threatening obstruction. Other tracheobronchial manifestations include segmental stenoses, mucosal edema, cobblestoning, ulcers, pseudomembranes, submucosal tunnels, and inflammatory pseudotumors. On CT, airway disease appears as concentric wall thickening of bilateral segmental and subsegmental bronchi with possible atelectasis or air‑trapping. Bronchoscopy is essential for mucosal evaluation and tissue sampling, though endobronchial biopsies often show only nonspecific granulation tissue. Management combines systemic immunosuppression (glucocorticoids with cyclophosphamide/rituximab for severe disease, methotrexate/azathioprine for mild disease) with bronchoscopic interventions or open surgical reconstruction as needed.
- References
- Keywords